292 related articles for article (PubMed ID: 26344167)
21. Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
Li Y; Ma J; Guo Q; Duan F; Tang F; Zheng P; Zhao Z; Lu G
Dis Esophagus; 2009; 22(8):664-7. PubMed ID: 19191857
[TBL] [Abstract][Full Text] [Related]
22. CADM1 mRNA expression and clinicopathological significance in esophageal squamous cell carcinoma tissue.
Qian JB; Liu HB; Zhu Y; Lu F; Yang QC; Shen Y
Genet Mol Res; 2017 May; 16(2):. PubMed ID: 28510248
[TBL] [Abstract][Full Text] [Related]
23. [Expression of fascin in human esophageal squamous cell carcinoma and its clinical significance].
Qin YR; Tang H; Qiao JJ; Li FF; Ai JY
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1216-9. PubMed ID: 21764699
[TBL] [Abstract][Full Text] [Related]
24. [Expression level and clinical significance of LncRNA HOXA11-AS in esophageal squamous cell carcinoma patients].
Sun XY; Wang XF; Cui YB; Cao XG; Zhao RH; Wei HY; Cao W; Wu W
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):186-190. PubMed ID: 29575836
[No Abstract] [Full Text] [Related]
25. [Expression and clinical significance of COX-2, p-Stat3, and p-Stat5 in esophageal carcinoma].
Liu JR; Wang Y; Zuo LF; Li FL; Wang Y; Liu JL
Ai Zheng; 2007 May; 26(5):458-62. PubMed ID: 17672932
[TBL] [Abstract][Full Text] [Related]
26. [Expression of mir-106b in esophageal squamous cell carcinoma].
Xiao CY; Guo ZJ; Cao L; Ding XW; Liu Q; Wang XC
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Dec; 36(12):1667-1671. PubMed ID: 27998862
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological and prognostic significance of GPX2 protein expression in esophageal squamous cell carcinoma.
Lei Z; Tian D; Zhang C; Zhao S; Su M
BMC Cancer; 2016 Jul; 16():410. PubMed ID: 27388201
[TBL] [Abstract][Full Text] [Related]
28. Protein and gene expression characteristics of heterogeneous nuclear ribonucleoprotein H1 in esophageal squamous cell carcinoma.
Sun YL; Liu F; Liu F; Zhao XH
World J Gastroenterol; 2016 Aug; 22(32):7322-31. PubMed ID: 27621578
[TBL] [Abstract][Full Text] [Related]
29. [Expression of human Sel-1-like gene and its significance in esophageal cancer].
Li H; Zhan HQ; Zhang HF
Zhonghua Bing Li Xue Za Zhi; 2007 Jun; 36(6):370-4. PubMed ID: 17822620
[TBL] [Abstract][Full Text] [Related]
30. ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma.
Li M; Cui X; Shen Y; Dong H; Liang W; Chen Y; Hu J; Li S; Kong J; Li H; Zhao J; Li F
Hum Pathol; 2015 May; 46(5):707-15. PubMed ID: 25732110
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
32. [Expression of fascin and cytokeratin 14 in esophageal squamous cell carcinoma].
Xue LY; Song YM; Tong T; Luo W; Dong LJ; Zou SM; Zheng S; Bi R; Zhan QM; Lü N
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2494-8. PubMed ID: 18067814
[TBL] [Abstract][Full Text] [Related]
33. Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China.
Wang Y; Zhe H; Gao P; Zhang N; Li G; Qin J
Dis Esophagus; 2012 Aug; 25(6):560-5. PubMed ID: 22098156
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
35. Upregulated ataxia-telangiectasia group D complementing gene correlates with poor prognosis in patients with esophageal squamous cell carcinoma.
Lai W; Zhao J; Zhang C; Cui D; Lin J; He Y; Zheng H; Wu X; Yang M
Dis Esophagus; 2013; 26(8):817-22. PubMed ID: 23020249
[TBL] [Abstract][Full Text] [Related]
36. RhoC, vascular endothelial growth factor and microvascular density in esophageal squamous cell carcinoma.
Zhao ZH; Tian Y; Yang JP; Zhou J; Chen KS
World J Gastroenterol; 2015 Jan; 21(3):905-12. PubMed ID: 25624724
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological significance of c-MYC in esophageal squamous cell carcinoma.
Lian Y; Niu X; Cai H; Yang X; Ma H; Ma S; Zhang Y; Chen Y
Tumour Biol; 2017 Jul; 39(7):1010428317715804. PubMed ID: 28671049
[TBL] [Abstract][Full Text] [Related]
38. Methylation and expression of PTPN22 in esophageal squamous cell carcinoma.
Deng J; Zhang J; Wang Ch; Wei Q; Zhou D; Zhao K
Oncotarget; 2016 Sep; 7(39):64043-64052. PubMed ID: 27613842
[TBL] [Abstract][Full Text] [Related]
39. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo].
Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH
Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822
[TBL] [Abstract][Full Text] [Related]
40. Expression and Significance of TRIM 28 in Squamous Carcinoma of Esophagus.
Liu B; Li X; Liu F; Li F; Wei S; Liu J; Lv Y
Pathol Oncol Res; 2019 Oct; 25(4):1645-1652. PubMed ID: 30484263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
